Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
AT7519
Description:
AT7519 is a small-molecule inhibitor of cyclin-dependent kinases investigated as an anticancer drug in laboratory and clinical research.
Related topics:
Cancer-related Molecular Pathways (12%),
Computational Drug Discovery Methods (11%)
Wikidata ID:
wiki/Q27074569
OpenAlex ID:
keywords/at7519
CDK inhibitors in cancer therapy, an overview of recent development.
2021
·
Mengna Zhang
, Lingxian Zhang
, et al.
·
PubMed
·
393
Identification of N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design
2008
·
Paul G. Wyatt
, Andrew J. Woodhead
, et al.
·
Journal of Medicinal Chemistry
·
378
Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
2009
·
Matthew S. Squires
, Ruth E. Feltell
, et al.
·
Molecular Cancer Therapeutics
·
184
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition
2010
·
L Santo
, S Vallet
, et al.
·
Oncogene
·
151
Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy
2017
·
Yan Kong
, Xinan Sheng
, et al.
·
Clinical Cancer Research
·
110
A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
2011
·
D. Mahadevan
, R. Plummer
, et al.
·
Annals of Oncology
·
103
PDF
The CDK inhibitor AT7519 inhibits human glioblastoma cell growth by inducing apoptosis, pyroptosis and cell cycle arrest
2023
·
Wenpeng Zhao
, Liang Zhang
, et al.
·
Cell Death and Disease
·
89
Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung
2013
·
C D Lucas
, D A Dorward
, et al.
·
Mucosal Immunology
·
88
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
2015
·
M. Emmy M. Dolman
, Evon Poon
, et al.
·
Clinical Cancer Research
·
78
A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177
2014
·
E X Chen
, S Hotte
, et al.
·
British Journal of Cancer
·
77
PDF
AT7519, a Cyclin-Dependent Kinase Inhibitor, Exerts Its Effects by Transcriptional Inhibition in Leukemia Cell Lines and Patient Samples
2010
·
Matthew S. Squires
, Laurence Cooke
, et al.
·
Molecular Cancer Therapeutics
·
60
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
2020
·
Harri M. Itkonen
, Ninu Poulose
, et al.
·
Molecular Cancer Research
·
57
The cyclin-dependent kinase inhibitor AT7519 accelerates neutrophil apoptosis in sepsis-related acute respiratory distress syndrome
2016
·
David A Dorward
, Jennifer M Felton
, et al.
·
Thorax
·
55
PDF
Delayed neutrophil apoptosis may enhance NET formation in ARDS
2022
·
Chao Song
, Haitao Li
, et al.
·
Respiratory Research
·
51
PDF
Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy
2019
·
Longwen Xu
, Zhiyuan Cheng
, et al.
·
Journal of Translational Medicine
·
43
PDF
Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss
2018
·
Robert A. Hazlitt
, Tal Teitz
, et al.
·
Journal of Medicinal Chemistry
·
40
Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer
2019
·
Changlei Xi
, Ling Wang
, et al.
·
Biochemical and Biophysical Research Communications
·
39
Induction of Eosinophil Apoptosis by the Cyclin-Dependent Kinase Inhibitor AT7519 Promotes the Resolution of Eosinophil-Dominant Allergic Inflammation
2011
·
Ana L. Alessandri
, Rodger Duffin
, et al.
·
PLoS ONE
·
39
PDF
Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer
2018
·
Mi Kang
, Wonwoo Kim
, et al.
·
International Journal of Oncology
·
35
PDF
Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer
2021
·
Aslamuzzaman Kazi
, Liwei Chen
, et al.
·
Clinical Cancer Research
·
33
PDF
Development of a CDK10/CycM in vitro Kinase Screening Assay and Identification of First Small-Molecule Inhibitors
2020
·
Thomas Robert
, Jared L. Johnson
, et al.
·
Frontiers in Chemistry
·
31
PDF
Bifunctional degraders of cyclin dependent kinase 9 (CDK9): Probing the relationship between linker length, properties, and selective protein degradation
2023
·
Robert J. Tokarski
, Chia M. Sharpe
, et al.
·
European Journal of Medicinal Chemistry
·
30
Selective Cdk9 inhibition resolves neutrophilic inflammation and enhances cardiac regeneration in larval zebrafish
2021
·
Aryan Kaveh
, Finnius A. Bruton
, et al.
·
Development
·
26
PDF
Phase 1 study of the HSP90 inhibitor onalespib in combination with AT7519, a pan-CDK inhibitor, in patients with advanced solid tumors
2020
·
Khanh T. Do
, Geraldine O’Sullivan Coyne
, et al.
·
Cancer Chemotherapy and Pharmacology
·
24
Cyclin‐dependent kinase 5 regulates degranulation in human eosinophils
2014
·
Solomon O. Odemuyiwa
, Ramses Ilarraza
, et al.
·
Immunology
·
18
PDF
Show more works
View as search
Works count:
119
Citation count:
2,452
Year
Topic
Type